Urgency Urinary Incontinence. Urge incontinence
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, patients will receive a 1-gram cinnamon capsule (Dr. Abidi Company) daily for 6 weeks. Intervention 2: Control group: In the placebo grou
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: All women with urgency urinary incontinence Having informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Presence of systemic diseases such as chronic liver disorders, kidney disorders, and diabetes Presence of autoimmune diseases such as multiple sclerosis and neurological disorders Presence of cystocele and rectocele History of allergy to cinnamon and its derivatives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of nocturia episodes per night. Timepoint: At baseline, 3 weeks, and 6 weeks after the intervention. Method of measurement: Asking the patient.;Daily urinary frequency. Timepoint: At baseline, 3 weeks, and 6 weeks after the intervention. Method of measurement: Asking the patient.;Number of daily urgency urinary incontinence episodes. Timepoint: At baseline, 3 weeks, and 6 weeks after the intervention. Method of measurement: Asking the patient.;Number of daily urinary urgency episodes. Timepoint: At baseline, 3 weeks, and 6 weeks after the intervention. Method of measurement: Asking the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Maryam Shokrpour
Arak University of Medical Sciences
Outcome results
None listed